Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 3.450 | 3.450 | 0.000 |
Stocks | 97.050 | 97.050 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 20.133 | 20.566 |
Price to Book | 6.165 | 4.169 |
Price to Sales | 5.713 | 2.466 |
Price to Cash Flow | 20.833 | 17.017 |
Dividend Yield | 1.112 | 1.350 |
5 Years Earnings Growth | 36.189 | 13.676 |
Number of long holdings: 29
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 9.10 | 767.76 | +1.35% | |
Vertex | US92532F1003 | 8.98 | 397.27 | +0.16% | |
Regeneron Pharma | US75886F1075 | 8.60 | 701.85 | -0.90% | |
Novo Nordisk B | DK0062498333 | 7.25 | 589.2 | -20.72% | |
AstraZeneca | GB0009895292 | 7.23 | 10,256.0 | +0.12% | |
Amgen | US0311621009 | 6.90 | 263.38 | +0.84% | |
Gilead | US3755581036 | 5.85 | 92.57 | +1.62% | |
Intuitive Surgical | US46120E6023 | 4.18 | 524.43 | +0.10% | |
AbbVie | US00287Y1091 | 3.92 | 175.58 | +2.37% | |
Lonza Group | CH0013841017 | 3.88 | 531.00 | +0.53% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Nomura Taiwan Superior Equity Fund | 24.17B | 17.01 | 10.31 | 18.31 | ||
Nomura Global Equity Fund TWD | 10.29B | 31.61 | 10.68 | 11.49 | ||
Nomura Taiwan Small Cap Fund | 9.96B | 19.45 | 12.90 | 19.28 | ||
Nomura Taiwan Growth Fund | 2.79B | 17.63 | 13.51 | 17.91 | ||
Nomura Taiwan Aggressive Growth Sel | 2.06B | 17.58 | 13.50 | 18.13 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review